title: Comparison of first- and second-wave DAAs for HCV GT1: efficacy, safety, tolerability, and regimen complexity.
authors.affiliation: Division of Gastroenterology & Hepatology, Department of Medicine, University of California, San Francisco, CA, USA.
authors.forename: Blaire E
authors.initials: BE
authors.lastname: Burman
authors.affiliation: Division of Gastroenterology & Hepatology, Department of Medicine, Indiana University, Indianapolis, IN, USA.
authors.forename: Paul Y
authors.initials: PY
authors.lastname: Kwo
authors.affiliation: Benaroya Research Institute, University of Washington, 1201 9th Ave, Seattle, WA, 98101, USA. kkowdley@benaroyaresearch.org.
authors.forename: Kris V
authors.initials: KV
authors.lastname: Kowdley
keywords: Direct-acting antivirals; Hepatitis C